<resource xmlns:datacite="http://datacite.org/schema/kernel-4">
<creators>
<creator>
<creatorName nameType="Personal">Andrea Klang</creatorName>
<givenName>Andrea</givenName>
<familyName>Klang</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Christof A. Bertram</creatorName>
<givenName>Christof A.</givenName>
<familyName>Bertram</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Taryn A. Donovan</creatorName>
<givenName>Taryn A.</givenName>
<familyName>Donovan</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Linden E. Craig</creatorName>
<givenName>Linden E.</givenName>
<familyName>Craig</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Ingrid Walter</creatorName>
<givenName>Ingrid</givenName>
<familyName>Walter</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Birgitt Wolfesberger</creatorName>
<givenName>Birgitt</givenName>
<familyName>Wolfesberger</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Brigitte Degasperi</creatorName>
<givenName>Brigitte</givenName>
<familyName>Degasperi</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Elisabeth Baszler</creatorName>
<givenName>Elisabeth</givenName>
<familyName>Baszler</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Barbara C. Rütgen</creatorName>
<givenName>Barbara C.</givenName>
<familyName>Rütgen</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Sabine E. Hammer</creatorName>
<givenName>Sabine E.</givenName>
<familyName>Hammer</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Andrea Fuchs-Baumgartinger</creatorName>
<givenName>Andrea</givenName>
<familyName>Fuchs-Baumgartinger</familyName>
</creator>
</creators>
<titles>
<title>Feline eosinophilic sclerosing fibroplasia associated with T-/natural killer-cell lymphoma</title>
</titles>
<publisher>Sage</publisher>
<publicationYear>2024</publicationYear>
<descriptions>
<description descriptionType="Other">Feline eosinophilic sclerosing fibroplasia (FESF) is a proliferative, inflammatory disease of the gastrointestinal tract and other sites, uncommonly diagnosed in the cat. This entity of uncertain etiology typically presents as a progressive mass lesion, mimicking a neoplastic process. In this case series, we present 17 cases of FESF associated with intralesional lymphoma. Histologic and immunohistochemical characterization of this unique lymphoma revealed that the neoplastic lymphocytes were immunopositive for CD56 and/ or CD3, suggesting a natural killer cell, natural killer T-cell, or T-cell origin. This case series represents the first description of this lymphoma subtype, for which the term eosinophilic sclerosing lymphoma is proposed.</description>
</descriptions>
<resourceType resourceTypeGeneral="Text">PDFDocument</resourceType>
<language>eng</language>
<dates>
<date dateType="Created">2025-04-01T08:19:21.317746Z</date>
<date dateType="Issued">2024</date>
</dates>
<subjects>
<subject>Cats</subject>
<subject>Animals</subject>
<subject>Cat Diseases Pathology</subject>
<subject>Cat Diseases Diagnosis</subject>
<subject>Male</subject>
<subject>Female</subject>
<subject>Lymphoma, T-Cell Veterinary</subject>
<subject>Lymphoma, T-Cell Pathology</subject>
<subject>Lymphoma, T-Cell Diagnosis</subject>
<subject>Immunohistochemistry Veterinary</subject>
<subject>Killer Cells, Natural Pathology</subject>
<subject>Eosinophils Pathology</subject>
</subjects>
<sizes>
<size>2366478 b</size>
</sizes>
<formats>
<format>application/pdf</format>
</formats>
<rightsList>
<rights rightsURI="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</rights>
</rightsList>
</resource>
